Introducing a Dengue Vaccine to Mexico: Development of a System for Evidence-Based Public Policy Recommendations

Open Access

The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.

Miguel Betancourt-Cravioto ,

* E-mail: mbetancourt@salud.carlosslim.org

Affiliation Carlos Slim Health Institute, Mexico City, Mexico
⨯
Pablo Kuri-Morales,

Affiliation Ministry of Health, Mexico City, Mexico
⨯
Jesús Felipe González-Roldán,

Affiliation National Center for Disease Control and Prevention, Ministry of Health, Mexico City, Mexico
⨯
Roberto Tapia-Conyer,

Affiliation Carlos Slim Foundation, Mexico City, Mexico
⨯
the Mexican Dengue Expert Group

¶Membership of the Mexican Dengue Expert Group is provided in the Acknowledgments.
⨯

Reader Comments (0)

Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Dengue fever
Is the Subject Area "Dengue fever" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Mexico
Is the Subject Area "Mexico" applicable to this article?

Thanks for your feedback.
Public and occupational health
Is the Subject Area "Public and occupational health" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Mexican people
Is the Subject Area "Mexican people" applicable to this article?

Thanks for your feedback.